Drug Information

G. K. McEvoy, ed.,MHFS Drug Information, American Society of Health-System Pharmacists, Bethesda, Md., 1995, pp. 2439. [Pg.110]

International Nonproprietay Names for Pharmaceutical Substances, Cumulative Eist No. < , Wodd Health Organization, Geneva, Switzedand, 1988 WHO Drug Inform. 6(3) and Special Section (1992). [Pg.122]

J. P. Hickey, A. Aldridge, D. R. May Passino, A. M. Frank, Expert System Predicts Aquatic Toxicityfrom Contaminant Chemical Structure,NMoa-A Fisheries Research Center-Great Lakes, U.S. Fish and Wildlife Service, Ann Arbor, Mich., 1991 Ibid., Drug Information Journal 26, 487 (1992). [Pg.259]

Finger Lakes Regional Poison Drug Information Center... [Pg.315]

M. Gross, A. Cartwright, B. Campbell, R. Bolton, K. Holmes, K. Kirkland, T. Salmonson, J.-L. Robert. Regulatory Requirements for chiral drugs. Drug Information J. 1993, 27, 453-457. [Pg.341]

The regulations also address the need to ensure that drug information provided by pharmaceutical firms is truthful, balanced, and accurately communicated. As such, it must be consistent with the indications for use and the established performance and limitations. In Europe, the directives do not impose a specific requirement to review advertising or promotional material before it is released. Acceptable standards may be achieved via voluntary codes of practice and self-regulation. However, national authorities must monitor such material and should have the power to act where the need arises. In the U S, the F DA must vet advertising and promotional material before it is released. [Pg.262]

Gittins, J. Quantitative methods in the planning of pharmaceutical research. Drug Inform J 1996 30 459-87. [Pg.273]

Hyde AW, Amersham N. The changing face of electronic data capture from remote data entry to direct data capture. Drug Inform J 1998 32 1089-1092 0092-8615/98. [Pg.630]

A drug information resource for Australian school communities, containing a comprehensive database of information about resources, policies and materials for drug education and incident management. Website www.redi.gov.au/default.asp... [Pg.156]

Dugas, M. et ah, Design and implementation of a common drug information database for a university hospital, Pharm. World ScL, 25, 156, 2003. [Pg.580]

Information dissemination Published distributed to physicians Report to MOH, DRA and industry Reported to Drug Council Published in newsletters Published in Drug Information Bulletin Advised to DCA Feedback sent to registration holders Info, to prescribers Information disseminated in local workshops y DRA is informed Published in CENAVIF bulletin Published in quarterly Drugs and Toxicology Bulletin... [Pg.91]

National Clearinghouse for Alcohol and Drug Information P.O. Box 2345 Rockville, MD 20852... [Pg.358]

Lacy C, Armstrong L, Goldman M, Lance L. Lexi-Comp s Drug Information Handbook, 12th edition. 2004 1128-11 32. [Pg.1165]

McEvoy G eds. AHFS Drug Information. ASHP. Bethesda, MD. 2005. [Pg.1168]

Director, Drug Information Service, NIH Clinical Center... [Pg.1686]

Associate Professor of Pharmacy Practice Idaho State University College of Pharmacy Director of Idaho Drug Information Service Pocatello, Idaho Chapter 48 Erectile Dysfunction... [Pg.1689]

Drug Information Specialist University of Virginia Health System Charlottesville, Virginia Chapter 59 Allergic Rhinitis... [Pg.1691]

Clinical Assistant Professor University of Georgia College of Pharmacy Drug Information and Formulary Coordinator MCG Health, Inc. [Pg.1696]

Assistant Professor and Drug Information Specialist Samford University McWhorter School of Pharmacy Birmingham, Alabama... [Pg.1699]

Hazel H. Seaba, M.S. Professor (Clinical) and Director, Division of Drug Information Service, College of Pharmacy, University of Iowa, Iowa City, Iowa... [Pg.11]

Ling CA. Guiding patients through the maze of drug information on the Internet. Am J Health-Syst Pharm 56 212-214, 1999. [Pg.745]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...